Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Ottawa

$25,000.00

Toward new reagents for biomedical applications

EF 2016-17

Résumé
Carbodiimides are important reagents to form amide bonds, which is a key functional group present in biologically active molecules. For example, the automated peptide synthesis that is now widely used in biomedical research (e.g. drug discovery) - and for which the Nobel prize was awarded to Merrifield in 1984 - relies on coupling agents such as carbodiimides to assemble peptides from simple amino acids. Other important biologically active molecules containing amides bonds, such as agrochemicals and pharmaceuticals, are produced using carbodiimides. However, despite decades of innovation, coupling agents still face limitations in reactivity that require new reagents and protocols.This proposal aims to use the expertise of Beauchemin on a new family of isocyanates (nitrogen-substituted isocyanates) to assemble and explore the reactivity of two families of unique carbodiimides that have never been investigated in the context of coupling reactions. The expertise of Matrix Innovation in reagents and strategies used to form amide bonds will be a true asset to guide R & D efforts aimed at the commercialization of unique carbodiimides that should be more reactive than the current standard reagents. The collaboration will also include benchmarking reactions in the context of normal, industrially relevant reactions, and of difficult coupling reactions. Overall, this research would lead to improved reagents of established industrial and biomedical importance, and prove financially rewarding for Matrix Innovation.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
492288-2015
Name nom
Beauchemin, André
Department département
Chemistry
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Toward new reagents for biomedical applications
Keyword
NSERC
Application summary
Carbodiimides are important reagents to form amide bonds, which is a key functional group present in biologically active molecules. For example, the automated peptide synthesis that is now widely used in biomedical research (e.g. drug discovery) - and for which the Nobel prize was awarded to Merrifield in 1984 - relies on coupling agents such as carbodiimides to assemble peptides from simple amino acids. Other important biologically active molecules containing amides bonds, such as agrochemicals and pharmaceuticals, are produced using carbodiimides. However, despite decades of innovation, coupling agents still face limitations in reactivity that require new reagents and protocols.This proposal aims to use the expertise of Beauchemin on a new family of isocyanates (nitrogen-substituted isocyanates) to assemble and explore the reactivity of two families of unique carbodiimides that have never been investigated in the context of coupling reactions. The expertise of Matrix Innovation in reagents and strategies used to form amide bonds will be a true asset to guide R & D efforts aimed at the commercialization of unique carbodiimides that should be more reactive than the current standard reagents. The collaboration will also include benchmarking reactions in the context of normal, industrially relevant reactions, and of difficult coupling reactions. Overall, this research would lead to improved reagents of established industrial and biomedical importance, and prove financially rewarding for Matrix Innovation.